>
Episode 470: A FOOD CRISIS, AUTISM COMMUNICATION RIGHTS, AND STEM CELL...
A Case For Jesus Christ - Lee Strobel | PBD #770
Situation with the war has finally made me use fuel stabilizer for my diesel fuel.
Could the War Trigger a Financial Reset & Usher in a CBDC Beast System? w/ Micah Haince
DARPA O-Circuit program wants drones that can smell danger...
Practical Smell-O-Vision could soon be coming to a VR headset near you
ICYMI - RAI introduces its new prototype "Roadrunner," a 33 lb bipedal wheeled robot.
Pulsar Fusion Ignites Plasma in Nuclear Rocket Test
Details of the NASA Moonbase Plans Include a Fifteen Ton Lunar Rover
THIS is the Biggest Thing Since CGI
BACK TO THE MOON: Crewed Lunar Mission Artemis II Confirmed for Wednesday...
The Secret Spy Tech Inside Every Credit Card
Red light therapy boosts retinal health in early macular degeneration

3 patients experienced complete remission after regularly taking fenbendazole.
But the cancer industry seems to hate it because it only costs about $11 per week.
Fenbendazole (FBZ) is a medicine originally designed to treat worms and parasites in animals. Its sister drugs, Mebendazole and Albendazole, have had remarkable success treating similar ailments in humans with few side effects.
The case series highlights the remarkable stories of three cancer patients who achieved miraculous recoveries with fenbendazole after exhausting all conventional therapies.
After analyzing these cases, the abstract concluded, "FBZ appears to be a potentially safe and effective antineoplastic agent that can be repurposed for human use in treating genitourinary malignancies."
Adding to the growing evidence in support of fendendazole's use case against cancer, an Oklahoma man credited his miraculous cancer recovery to the pet med after overcoming terminal small cell lung cancer, defying a less than 1% survival rate and leaving doctors baffled.
This story is truly remarkable. Watch.